Home › Ironwood starts IBS trial in China, but stock falls on analyst forecast
 

Keywords :   


Ironwood starts IBS trial in China, but stock falls on analyst forecast

2013-09-12 13:48:54| Biotech - Topix.net

Ironwood Pharmaceuticals Inc. has announced a late-stage trial in China seeking to get its irritable bowel syndrome drug approved there, but lost 4 percent of stock value after an analyst firm lowered his price target.

Tags: china stock trial falls

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 7
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
More »